Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of sEH Inhibition on Insulin Sensitivity
NCT03486223Phase 2Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- May 2018
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of GSK2256294 in prediabetes, sponsored by Vanderbilt University Medical Center. Started May 2018; status: completed.
02
Drugs
GSK2256294
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT03486223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03486223.